Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1673985/000167398523000073/asix-20230331.htm
August 2023
June 2023
May 2023
May 2023
April 2023
April 2023
February 2023
November 2022
October 2022
August 2022
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1673985/000167398523000073/asix-20230331.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Advansix Inc..
Advansix Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:
Rating
Learn More![]()
Non-GAAP Measures (Dollars in thousands, unless otherwise noted) 21 The following tables set forth the non-GAAP financial measures of Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income and Adjusted Earnings Per Share.
Cash Flow Summary Cash provided by operating activities decreased by $47.6 million for the three months ended March 31, 2023 versus the prior year period due primarily to a $28.1 million decrease in net income and a $36.6 million unfavorable cash impact from working capital (comprised of Accounts and other receivables, Inventories, Accounts payable and Deferred income and customer advances) year-over-year with a $57.3 million unfavorable cash impact from working capital for the three months ended March 31, 2023 compared to a $20.7 million unfavorable cash impact in the prior year period.
Dividends During 2023, the Company has declared dividends as follows: 19 Results of Operations (Dollars in thousands, unless otherwise noted) Sales The change in sales compared to the prior year period is attributable to the following: Sales decreased in the three months ended March 31, 2023 compared to the prior year period by $78.5 million (approximately 16%) due primarily to (i) decreased sales volume (approximately 9%) driven primarily by soft end market demand, (ii) net unfavorable market-based pricing (approximately 6%) reflecting lower pricing across our ammonium sulfate and nylon product lines, and (iii) lower raw material pass-through pricing (approximately 4%) as a result of net cost decreases in benzene and propylene (inputs to cumene which is a key feedstock to our products), partially offset by the acquisition of U.S. Amines (approximately 3%).
Cash used for financing activities increased by $80.1 million for the three months ended March 31, 2023 versus the prior year period due primarily to net borrowings of $12.0 million during the three months ended March 31, 2023 compared to net borrowings of $85.0 million during the prior year period partially offset by payments for share repurchases of $13.5 million and cash paid for dividends of approximately $4.0 million during the three months ended March 31, 2023 compared to $7.0 million and $3.5 million during the prior year period, respectively.
The Credit Agreement also contains...Read more
Selling, General and Administrative Expenses...Read more
While our integration, scale and...Read more
Capital Expenditures (Dollars in thousands,...Read more
Our cash flows are affected...Read more
Our ability to fund our...Read more
Recent Developments Share Repurchase Authorization...Read more
This was partially offset by...Read more
Due to the ammonium sulfate...Read more
Although we have ongoing environmental...Read more
Non-GAAP financial measures should be...Read more
The Company's non-GAAP measures may...Read more
We also utilize maintenance excellence...Read more
Actual results and the timing...Read more
If the Company does not...Read more
Nylon 6 resin prices generally...Read more
We continue to invest in...Read more
Our differentiated Nylon 6 products...Read more
Although we believe forward-looking statements...Read more
Capital expenditures are expected to...Read more
Substantially all tangible and intangible...Read more
We believe that Nylon 6...Read more
Most significant is acetone, the...Read more
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
Advansix Inc. provided additional information to their SEC Filing as exhibits
Ticker: ASIX
CIK: 1673985
Form Type: 10-Q Quarterly Report
Accession Number: 0001673985-23-000073
Submitted to the SEC: Fri May 05 2023 4:17:27 PM EST
Accepted by the SEC: Fri May 05 2023
Period: Friday, March 31, 2023
Industry: Plastic Materials Synth Resins And Nonvulcan Elastomers